198 results on '"Matsuo, Hidemasa"'
Search Results
2. Parbendazole as a promising drug for inducing differentiation of acute myeloid leukemia cells with various subtypes
3. Suppression of super-enhancer-driven TAL1 expression by KLF4 in T-cell acute lymphoblastic leukemia
4. Landscape of driver mutations and their clinical effects on Down syndrome–related myeloid neoplasms
5. Successful allogeneic bone marrow transplantation in a case of variant acute promyelocytic leukemia with ZBTB16-RARA
6. Author Correction: A RUNX-targeted gene switch-off approach modulates the BIRC5/PIF1-p21 pathway and reduces glioblastoma growth in mice
7. A RUNX-targeted gene switch-off approach modulates the BIRC5/PIF1-p21 pathway and reduces glioblastoma growth in mice
8. Machine learning-based prediction of relapse in rheumatoid arthritis patients using data on ultrasound examination and blood test
9. Positive rate and prognostic significance of the superb microvascular imaging signal in joints of rheumatoid arthritis patients in remission with normal C-reactive protein levels and erythrocyte sedimentation rates
10. Inhibition of CDK4/6 and autophagy synergistically induces apoptosis in t(8;21) acute myeloid leukemia cells
11. Donor‐derived CD8‐predominant T cells in human graft‐versus‐host disease of the brain after allogeneic transplantation.
12. Fusion partner–specific mutation profiles and KRAS mutations as adverse prognostic factors in MLL-rearranged AML
13. Label‐free cell detection of acute leukemia using ghost cytometry
14. Prediction of recurrence and remission using superb microvascular imaging in rheumatoid arthritis
15. Transcriptome analysis offers a comprehensive illustration of the genetic background of pediatric acute myeloid leukemia
16. P527: DISTINCTIVE CLONAL EVOLUTION PATTERN AND PROGNOSTIC SIGNIFICANCE OF THE CLONALITY OF KRAS MUTATIONS IN KMT2A-REARRANGED ACUTE MYELOID LEUKEMIA
17. Pivotal role of DPYSL2A in KLF4-mediated monocytic differentiation of acute myeloid leukemia cells
18. KRASG12 mutations as adverse prognostic factors in KMT2A-rearranged acute myeloid leukemia
19. RUNX1–Survivin Axis Is a Novel Therapeutic Target for Malignant Rhabdoid Tumors
20. Genetic regulation of the RUNX transcription factor family has antitumor effects
21. Purification of leukemic blast cells from blood smears using laser microdissection
22. Monitoring of fusion gene transcripts to predict relapse in pediatric acute myeloid leukemia
23. Multiplex fusion gene testing in pediatric acute myeloid leukemia
24. TP53 and RB1 alterations characterize poor prognostic subgroups in pediatric acute myeloid leukemia.
25. Fludarabine, cytarabine, granulocyte colony‐stimulating factor and idarubicin for relapsed childhood acute myeloid leukemia
26. Prediction of recurrence and remission using superb microvascular imaging in rheumatoid arthritis
27. RUNX1 transactivates BCR‐ABL1 expression in Philadelphia chromosome positive acute lymphoblastic leukemia
28. Clonal Evolution Pattern and Prognostic Significance of Clonal Architecture in KMT2A-Rearranged Acute Myeloid Leukemia
29. CXCR4 Overexpression is a Poor Prognostic Factor in Pediatric Acute Myeloid Leukemia With Low Risk: A Report From the Japanese Pediatric Leukemia/Lymphoma Study Group
30. Efficacy of a combination therapy targeting CDK4/6 and autophagy in a mouse xenograft model of t(8;21) acute myeloid leukemia
31. Albendazole induces the terminal differentiation of acute myeloid leukaemia cells to monocytes by stimulating the Krüppel‐like factor 4‐dihydropyrimidinase‐like 2A (KLF4‐DPYSL2A) axis
32. Droplet digital polymerase chain reaction assay for the detection of the minor clone of KIT D816V in paediatric acute myeloid leukaemia especially showing RUNX1‐RUNX1T1 transcripts
33. RUNX inhibitor suppresses graft‐versus‐host disease through targeting RUNX‐NFATC2 axis
34. Acute myeloid leukaemia with myelodysplastic features in children: a report of Japanese Paediatric Leukaemia/Lymphoma Study Group
35. Suppression of super-enhancer-driven TAL1expression by KLF4 in T-cell acute lymphoblastic leukemia
36. Clinical significance of RAS pathway alterations in pediatric acute myeloid leukemia
37. RUNX-NFAT Axis As a Novel Therapeutic Target for AML and T Cell Immunity
38. KRAS mutations Frequently Coexist with High-Risk MLL Fusions and Are Independent Adverse Prognostic Factors in MLL-Rearranged Acute Myeloid Leukemia
39. Autophagy Inhibition Enhances CDK4/6 Inhibitor-Induced Apoptosis in t(8;21) Acute Myeloid Leukemia Cells
40. RUNX1 transactivates BCR‐ABL1 expression in Philadelphia chromosome positive acute lymphoblastic leukemia.
41. Blast cells in acute megakaryoblastic leukaemia with Down syndrome are characterized by low CLEC12A expression
42. Inhibition of CDK4/6 and autophagy synergistically induces apoptosis in t(8;21) acute myeloid leukemia cells
43. TXNIP induces growth arrest and enhances ABT263‐induced apoptosis in mixed‐lineage leukemia‐rearranged acute myeloid leukemia cells
44. The Detection of Minor Clones with Somatic KIT D816V Mutations Using Droplet Digital PCR in Pediatric De Novo AML: AML-05 Trial from the Japanese Pediatric Leukemia/Lymphoma Study Group
45. Clinical Features of Pediatric Acute Myeloid Leukemia with TP53 and CDKN2A/2B copy Number Alterations
46. Coexistence and Prognostic Significance of EVI1 Expression and Driver Mutations in KMT2A-Rearranged Acute Myeloid Leukemia
47. Recurrent Gene Mutations in Pediatric Patients with AML By Targeted Sequencing ―the Jccg Study, JPLSG AML-05―
48. レーザーマイクロダイセクションを用いた血液塗抹標本からの白血病細胞の純化)
49. EVI1 triggers metabolic reprogramming associated with leukemogenesis and increases sensitivity to L-asparaginase
50. Prediction of recurrence and remission using superb microvascular imaging in rheumatoid arthritis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.